Cells of the synovium in rheumatoid arthritis -: Macrophages

被引:255
作者
Kinne, Raimund W. [1 ]
Stuhlmueller, Bruno [2 ]
Burmester, Gerd-R [2 ]
机构
[1] Univ Clin, Dept Orthoped, Expt Rheumatol Unit, D-07607 Jena, Germany
[2] Humboldt Univ, Charite Univ Hosp, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany
关键词
D O I
10.1186/ar2333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The multitude and abundance of macrophage-derived mediators in rheumatoid arthritis and their paracrine/autocrine effects identify macrophages as local and systemic amplifiers of disease. Although uncovering the etiology of rheumatoid arthritis remains the ultimate means to silence the pathogenetic process, efforts in understanding how activated macrophages influence disease have led to optimization strategies to selectively target macrophages by agents tailored to specific features of macrophage activation. This approach has two advantages: ( a) striking the cell population that mediates/amplifies most of the irreversible tissue destruction and (b) sparing other cells that have no (or only marginal) effects on joint damage.
引用
收藏
页数:16
相关论文
共 144 条
[21]  
CHU CQ, 1991, CLIN EXP IMMUNOL, V86, P380
[22]   New cytokine targets in inflammatory rheumatic diseases [J].
Connell, Laura ;
McInnes, Iain B. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (05) :865-878
[23]   Therapeutic cocktails for rheumatoid arthritis: The mixmaster's guide [J].
Cronstein, BN .
ARTHRITIS AND RHEUMATISM, 2004, 50 (07) :2041-2043
[24]   Estrogens and arthritis [J].
Cutolo, M ;
Lahita, RG .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2005, 31 (01) :19-+
[25]   CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation [J].
Dalbeth, N ;
Gundle, R ;
Davies, RJO ;
Lee, YCG ;
McMichael, AJ ;
Callan, MFC .
JOURNAL OF IMMUNOLOGY, 2004, 173 (10) :6418-6426
[26]   Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages [J].
Dao, DN ;
Kremer, L ;
Guérardel, Y ;
Molano, A ;
Jacobs, WR ;
Porcelli, SA ;
Briken, V .
INFECTION AND IMMUNITY, 2004, 72 (04) :2067-2074
[27]  
DELEURAN BW, 1992, BRIT J RHEUMATOL, V31, P801
[28]   Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors [J].
Deng, GM ;
Zheng, LX ;
Chan, FKM ;
Lenardo, M .
NATURE MEDICINE, 2005, 11 (10) :1066-1072
[29]   Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice [J].
Dillon, SR ;
Sprecher, C ;
Hammond, A ;
Bilsborough, J ;
Rosenfeld-Franklin, M ;
Presnell, SR ;
Haugen, HS ;
Maurer, M ;
Harder, B ;
Johnston, J ;
Bort, S ;
Mudri, S ;
Kuijper, JL ;
Bukowski, T ;
Shea, P ;
Dong, DL ;
Dasovich, M ;
Grant, FJ ;
Lockwood, L ;
Levin, SD ;
LeCiel, C ;
Waggie, K ;
Day, H ;
Topouzis, S ;
Kramer, J ;
Kuestner, R ;
Chen, Z ;
Foster, D ;
Parrish-Novak, J ;
Gross, JA .
NATURE IMMUNOLOGY, 2004, 5 (07) :752-760
[30]   Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation [J].
Dinarello, CA .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (04) :378-385